MFDS imported drug management regulation
Regulation on Management of Imported Drugs
Current edition
MFDS Notice 2020-82, in force September 7, 2020
Current edition
MFDS Notice 2020-82, in force September 7, 2020
About this standard
Rules for imported drugs and quasi-drugs: customs clearance report, import control documents, quality testing bodies, and quality testing methods and procedures.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
South Korea
- Official quality testing of imported drugs after customs clearanceLot release and sample testing · Sample testing
- Testing and quality control of imported drugs by the importer (import control standard)Lot release and sample testing · Local test
Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.